◆ 会议时间：2025年5月24-26日
◆ 会议地点：奥地利 因斯布鲁克
◆ 会议简介：
2025年第52届欧洲钙化组织学会(ECTS)年会将于2025年5月24-26日在奥地利因斯布鲁克举行。ECTS大会将为肌肉骨骼领域的研究人员和临床医生提供了一个发现和讨论相关研究和患者日常护理方面最新进展和争议的平台。ECTS年会的教育内容包括会前课程、工作组会议和研讨会；同时还会有很多互动环节:与专家会面，ECTS-ASBMR临床辩论会，开幕式将回顾ECTS在过去一年发布的实践指南；与会者包括：研究人员、临床医生、基础科学家、护士或相关专业人士、行业代表等等，预计有1000余名代表出席会议。
欧洲钙化组织学会(ECTS)是代表欧洲肌肉骨骼领域研究人员和临床医生的首要组织，其使命是促进欧洲钙化组织领域宣的基础和临床研究，并传播这些研究结果，使患有代谢性骨病的患者受益。ECTS现拥有600多名成员，包括在肌肉骨骼领域工作的基础研究人员、临床医生、学生和相关专业人士。ECTS每年举办一次大会，并提供博士培训课程和众多研究资助工具，作为传播优秀科学成果和教育的平台。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。
ECTS 2025 - 52nd Annual Meeting of the European Calcified Tissue Society
Date:
24-26 May 2025 (pre-congress day on 23 May)
Venue:
Innsbruck, Austria
以下为上届会议信息
摘要征文投稿：
ABSTRACT SUBMISSION
Prepare your abstract or clinical case
Opening of the ECTS Online Submission is 11 September 2023.
Abstracts and Clinical Cases can be submitted via the online Abstract Submission Platform only.
The submission deadline is Tuesday 9 January 2024, 23:59 (CET).
点此提交摘要>>>Submit Abstract>>>
Abstract content
Language: English
Abstract Title Length: max. 25 words
Abstract Body Length: max. 300 words, incl. numbers and symbols. You can also use tables and images:
Tables: 1 table is accepted per abstract.
The words used in the table count toward the total word count of the abstract. It is recommended to use the table tool provided in the abstract body, instead of “cut & copy” your table.
Figures: 1 image is accepted per abstract.
The maximum file size is 2MB and 400(w) x 400(h) pixels. Images can only be submitted in JPG or PNG format. ECTS may adjust the size of the tables and images to fit files for final publication.
Images cannot be pasted but should be uploaded using the editor in the Abstract Body.
Abstracts will be considered for Oral presentation only if they include data in numbers, graphs and/or images (an exception applies for the clinical cases and innovative methods category).
Keywords: up to 5 Keywords may be assigned to your abstract.
Abstracts must be submitted in English, using the online form. For questions regarding the online submission process, please e-mail ects2024@netropolix.be.
A blind selection process will be used. No identifying features such as names of hospitals, medical schools, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. The names of authors and their affiliations (institutions) will be entered online when you submit the abstract.
The title should be as brief as possible but long enough to indicate clearly the nature of the study.
If possible, please structure your abstract using the following headings:
Background/Introduction
Purpose
Methods
Results
Conclusion(s)
Abstracts should be:
- As informative as possible
- State the specific objective of the study
- State the method used, if pertinent; state whether experiments were in vivo or in vitro
- Ethical approval should be indicated when experiments are performed on human subjects or animals
- Summarise the results obtained. Where a study generates hard data (numbers and statistics) this must be included within the abstract. For on-going studies or studies that are not completed yet, statements such as ‘results will be presented’ are not accepted
- Abstracts must include data, as this is the main component of the abstract. Authors must include a clear description of the results and all appropriate data in sufficient detail to support any conclusion they wish to make within the abstract; an abstract without supporting data will be rejected
- State the conclusions reached.
Presentation & registration
The submission of an abstract constitutes a commitment by the author to present their abstract at the congress once accepted.
For an abstract to be included in the final scientific program, it is mandatory for the presenting author to register for the congress and to settle payment as soon as the notification of abstract acceptance is received and not later than Friday, 24 March 2024.
Expenses associated with the preparation, submission and presentation of an abstract are responsibility of the presenter(s)/author(s).
Failure to register for the Congress by the deadline of 24 March 2024 will lead to the withdrawal of the abstract and an administrative fee of 50,00 €.
注册费：
Registration fees include relevant VAT and are cashed in Euro (€) only.
MAIN CONGRESS
|
Early fee
In-person and On-Demand
Until 24 March 2024
|
Regular fee
In-person and On-Demand
24 March – 26 April 2024 |
Late/Onsite Fee
In-person and On-Demand
From 26 April 2024
|
| ECTS Member |
€ 595,00 |
€ 740,00 |
€ 880,00 |
| Non-Member |
€ 840,00 |
€ 980,00 |
€ 1100,00 |
| Trainee, Nurses & Allied Health Professionals, Patient Group Representatives – Member |
€ 295,00 |
€ 360,00 |
€ 420,00 |
| Trainee, Nurses & Allied Health Professional – Non Member |
€ 360,00 |
€ 420,00 |
€ 470,00 |
| Reach The World Reduced Fee* |
€ 270,00 |
€ 370,00 |
€ 480,00 |
PRE-CONGRESS DAY
|
Early fee
Until 24 March 2024
|
Regular fee
24 March – 26 April 2024 |
Late/Onsite Fee
From 26 April 2024
|
ECTS Member
|
€ 120,00 |
€ 150,00 |
€ 180,00 |
| Non-Member |
€ 180,00 |
€ 210,00 |
€ 240,00 |
| Trainee, Nurses & Allied Health Professionals, Patient Group Representatives – Member |
€ 75,00 |
€ 100,00 |
€ 125,00 |
| Trainee, Nurses & Allied Health Professional – Non Member |
€ 125,00 |
€ 155,00 |
€ 185,00 |
| Reach The World Reduced Fee* |
€ 70,00 |
€ 95,00 |
€ 120,00 |
FULL MEETING PACKAGE (PRE-AND MAIN CONGRESS)
| |
Early fee
In-person and On-Demand
Until 24 March 2024 |
Regular fee
In-person and On-Demand
24 March – 26 April 2024
|
Late/Onsite Fee
In-person and On-Demand
From 26 April 2024 |
| ECTS Member |
€ 715,00 |
€ 890,00 |
€ 1060,00 |
| Non-Member |
€ 1020,00 |
€ 1190,00 |
€ 1340,00 |
| rainee, Nurses & Allied Health Professionals, Patient Group Representatives – Member |
€ 370,00 |
€ 460,00 |
€ 545,00 |
| Trainee, Nurses & Allied Health Professionals, Patient Group Representatives – Non-Member |
€ 485,00 |
€ 575,00 |
€ 655,00 |
| Reach The World Reduced Fee* |
€ 340,00 |
€ 465,00 |
€ 600,00 |
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
